[Management of osteoporosis at a primary care center].
OBJECTIVE
To find how suitable a semFYC guide is for the indication of bone densitometry in menopausal women; and how appropriate their Osteoporosis treatment is.


METHODS
Cross-sectional study.Setting. Girona-3 Health District.


METHODS
Women between 50 and 80 allocated to the Girona-3 Health District. Suffering a grave psychiatric disorder or a terminal illness were considered criteria for exclusion. 409 out of the 420 women envisaged were included, to achieve a 5% accuracy and a 0.05% alpha error.


METHODS
Whether bone densitometry took place or otherwise, other diagnostic tests, risk factors for osteoporosis recorded and drug treatment prescribed.


RESULTS
Of the 125 women with risk factors for osteoporosis, 12 (9.6%) had had a bone densitometry. 20% of all bone densitometries done showed pathology. Only in 3 cases (0.7%) of the pathological cases was any recommendation on life-style recorded. 19.8% of the women took drug treatment. In 8% this was justified. The most common treatment prescribed was calcium, on its own or linked to vitamin D. 20% of cases had a bone densitometry to monitor them after 2 years.


CONCLUSIONS
The indication for bone densitometry is low and its use could be improved. In those cases in which bone densitometry is requested, a pharmacological intervention is more common than a life-style one.
Zwart Salmerón
M
M
Médico de Familia, EAP Girona-1, ICS, Girona, España. mzwart@scmfic.org
Fradera Vilalta
M
M
Solanas Saura
P
P
González Pastor
C
C
Adalid Vilar
C
C
D000368:Aged; D002118:Calcium / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003720:Densitometry; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy*; D010818:Practice Patterns, Physicians'; D011320:Primary Health Care; D012307:Risk Factors; D013030:Spain; D014807:Vitamin D / Q000627:therapeutic use
D014807:Vitamin D; D002118:Calcium